Clinical Trial Update: Interleukin-2 With or Without Histamine Dihydrochloride in Treating Patients With Stage IV Melanoma Metastatic to the Liver [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating interleukin-2 with or without histamine dihydrochloride in patients with stage IV melanoma that has metastasized to the l…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Histamine dihydrochloride (histamine dihydrochloride)
• Interleukin-2 (interleukin-2)

Snippet

Sponsor: Maxim Pharmaceuticals | Conditions: Melanoma (Skin), Metastatic Cancer | Phase 3 | Status: UNKNOWN